Top compounds associated with response to TNXB


Feature Type Standardized
Nominal ANOVA
mRNA sotrastaurin CTRPv2 pan-cancer AAC -0.014 0.7
mRNA momelotinib CTRPv2 pan-cancer AAC -0.012 0.7
mRNA WZ4002 CTRPv2 pan-cancer AAC -0.016 0.7
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.018 0.7
mRNA ML312 CTRPv2 pan-cancer AAC -0.024 0.7
mRNA foretinib CTRPv2 pan-cancer AAC -0.012 0.7
mRNA lovastatin CTRPv2 pan-cancer AAC 0.013 0.7
mRNA BIBW2992 FIMM pan-cancer AAC 0.052 0.7
mRNA HLI 373 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA Erlotinib gCSI pan-cancer AAC -0.018 0.7
Download CSV